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Recently much attention has been given to the classification of leukemia according 
to B- and T-cell origins. Wilson and Nossal (1)  indicated that acute lymphoblastic 
leukemia  (ALL)  t  might  be  a  leukemia of  T  cells and  chronic  lymphatic leukemia 
(CLL) might be that of B cells. Since Iwakata and Grace (2) succeeded in the perma- 
nent culture of a  hematopoietic cell line from the peripheral blood of a  patient with 
acute  myelogenous leukemia,  many  cell lines were  successfully established.  These 
cell  lines  produced  immunoglobulins  (3),  and  had  receptors  for  complement  and 
antigen-antibody complex. The cells showed clumps floating in the media. The presence 
of surface-bound immunoglobulins (4-6) and of receptors for complement (7, 8) and 
antigen-antibody complex on  the membranes  (8,  9)  were  considered to be markers 
for B lymphocytes. 
Recently, Minowada et al. (10,  11) succeeded in the establishment of the lymphoid 
cell lines (called MOLT and SOMMER)  from the peripheral blood of patients with 
ALL. MOLT  cells did not have  immunoglobulins on  the  surface, nor receptors for 
antigen-antibody complex, but bound sheep red blood cells (SRBC) to form rosettes. 
None of the B-cell lines so far established bound SRBC. SOMMER T cells had similar 
characteristics to MOLT cells although the percentage of rosette formation was lower. 
The formation of spontaneous rosettes with SRBC in humans was considered to be a 
marker for T  cells (6,  12).  MOLT and  SOMMER  cells do not form clumps in  the 
media. Furthermore, it has been shown that cytotoxicity of rabbit anti-MOLT serum 
was  absorbed with  fresh  human  thymocytes, but  not  with  human  B  cells or liver 
(unpublished observation). We have recently shown that MOLT cells have antigenic 
determinants shared with human brain (13).  Shared antigenic determinants between 
thymocyte and brain have been reported in the rat and mouse (14,  15). As Minowada 
and Moore have shown (11), rabbit anti-MOLT sera specifically  killed cells from most 
of the patients with ALL, but did not kill cells from most of the patients with CLL. 
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the National Cancer  Institute, and  AI-08899 from  the National Institute of Allergy and 
Infectious Disease, and General Research Support Grant RR-05648-07. 
1  Abbreviations used in  this paper: ALL,  acute  lymphoblastic leukemia;  BGG,  bovine 
gamma globulin; CLL, chronic lymphatic leukemia; CRBC, chicken red blood cells. 
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It has been shown  that  T  cells produced  immunoenhancing  factors  upon  contact 
with  antigens  (16-20).  Besides these immunoenhancing  factors,  the suppressive role 
of  the  thymus  has  been  suggested  (21).  Although  "suppressor  T-cells"  attracted 
interests of many investigators (22-25), no direct evidence was presented that T  cells 
elaborated immunosuppressive factors upon contact with antigens in vitro. Okumura 
and  Tada  (25)  reported  that  antigen-specific T-cell factor gave a  strong  inhibiting 
effect on the ongoing homocytotropic antibody response in rats. 
In  the  present  communication  we  report  on  the  presence  of  immunosup- 
pressive factors  in  the  supernate  of  the mixture  of SRBC  and  MOLT-4  cells. 
Since  these  factors  were  not  released  from  the  mixture  of  chicken  red  blood 
cells (CRBC)  and MOLT  cells (MOLT  cells do  not form rosettes on CRBC), 
these factors may be released from MOLT  cells forming rosettes with SRBC. 
Materials and Methods 
Cell Liues.--MOLT cells, T-cell line, were obtained as reported previously (10, 11) and one 
B-cell line established from a healthy male adult (RPMI 1788), was used as control B cells. 
They were grown at 37"C in a suspension culture  using  the  nutrient  medium  RPMI  1640 
(Grand Island Biological Co., Grand Island, N. Y.)  supplemented with  10%  (vol/vol) heat- 
inactivated fetal calf serum, penicillin (100 U/ml), and streptomycin (50 #g/ml). 
Tissue Cultures.-Marbrook's  method was used  (27).  The inner chamber consisted of a 
glass cylinder 8 cm long and  1 cm in diameter. The cylinder, of which one end was covered 
with a dialysis membrane, was set erect in a 2.5  X  5.5-cm glass vial and held in place with 
foam rubber (28). 
Preparation of Cdls.--The spleen cells were teased in a medium of CMRL 1066 and 20% 
fetal calf serum  (GIBCO). The culture medium contained antibiotics (penicillin 100 U/ml) 
and streptomycin  100 #g/ml,  (GIBCO) and  asparagine  (200/zg/ml). 
Antigen.--To 1 ml of the cell suspension was added 0.1 ml of 0.1% SRBC or CRBC suspen- 
sions,  and the mixture was cultured in a humidified incubator at 37°C in an atmosphere of 
5% CO2 in air. On day 5,  the cells were resuspended  and  were assayed  for plaque-forming 
cells (29, 30). 
Immunosuppressive Factors from the Mixture  of SRBC or CRBC and MOLT Cdls.--4 ml 
of MOLT-4 cells (1  X  107/ml) was mixed with 1 ml of 20% SRBC or CRBC solution, and 
the mixture was kept for 2 hours at 37°C,  then centrifuged for  10 rain at  1,800 rpm. The 
supernate was removed and diluted variously. As a control, 4 ml of MOLT-4 cells was mixed 
with 1 ml of media and incubated. For culture, 0.5 ml of the supernate from the mixture was 
added to 0.5 ml of CBA mouse spleen cell suspension (4 X  107/ml)  in the presence of 0.1 ml 
of 0.1% SRBC or CRBC. Methods for obtaining supernates in various experimental conditions 
were described in the text. 
Dialysis of the Supernate.--1  ml of the supernate obtained as above described was put  in 
the inside chamber of the culture unit. 9 ml of media was put in the outside chamber.  Since 
two chambers were separated by a dialysis membrane, factors should be found in the outside 
chamber if dialysable. The culture unit was kept at room temperature for 24 h. Solutions  in 
the inside and outside chambers were tested for immunosuppressive activities. 
RESULTS 
Effects  of MOLT-4  Cells and RPMI  1788 Cells on the Plaque Formation  of 
CBA  Mouse  Spleen  Cells.--Table  I  indicates  the  results  of  experiments  in 
which 5  X  105  or 5  X  104 MOLT-4  cells were added  to 2  X  106  CBA mouse 540  FUNCTIONS OF  HUMAN T-LYMPHOID CELL LINE  (MOLT) 
TABLE I 
Effects of MOLT-4 Cells and RPMI 1788 Cells on the Plaque Formation of CBA Mouse Spleen 
Cdls In Vitro 
No. of spleen cells  No. of cells  added*  No. of direct plaques1: 
1 X  107  none  37.8  4-  9.6 
1 X  107  1 X  107 mouse thymocytes§  100.5  -t-  13.1 
2 X  107  none  592.7  -t-  52.9 
2 X  107  1 X  107 mouse thymocytes  983.4  -4-  156.1 
2 X  107  5 X  105 MOLT-4 cells  47.00  ±  4.87 
2 X  107  5 X  104 MOLT-4 cells  369.6  ±  64.7 
2 X  107  5 X  105 RPMI 1788 cells  464.3  ±  38.5 
2 X  107  5 X  104 RPMI 1788 cells  558.6  ±  60.0 
* The numbers of mouse thymocytes, MOLT-4, or RPM! 1788 cells added to 
of mouse spleen cells. 
Mean 4- standard errors for 12 cultures. 
§ CBA mouse thymocytes. 
the culture 
spleen cells in  the presence of 0.1  ml  of 0.1%  SRBC.  As controls 0.5  or 5  X 
105 RPMI  1788 cells were added to the culture. As shown in the top two lines, 
1  X  107  CBA  mouse  spleen cells did not  generate  many  anti-SRBC  plaque- 
forming cells while the same number of spleen cells plus 1 X  107  CBA thymus 
cells generated enough numbers  of plaque-forming cells. 2  X  107  CBA  spleen 
cells showed many anti-SRBC plaque-forming cells on day 5  and the addition 
of 1  X  107  thymus cells further  increased the response.  By using this system, 
enhancing or suppressive effects of added T  cells could be  tested  in vitro. So 
we used 2 X  107 CBA spleen cells in the culture to know the effects of MOLT-4 
cells and  RPMI  1788  cells on  anti-SRBC  responses.  Lines five  and  six show 
that  5  X  104  or 5  X  105  MOLT-4  cells totally suppressed  CBA  anti-SRBC 
responses  in  vitro while lines seven  and  eight  showed  that  RPMI  1788  cells 
did not  suppress or enhance  anti-SRBC  responses. 
Effects of the Supernate of the Mixture  of MOLT-4 Cells and SRBC on A nti- 
SRBC  Plaque  Formation  of  CBA  Spleen  Cells.--Since  MOLT-4  cells  were 
immunosuppressive  when  mixed  with  CBA  mouse  spleen  cells,  as  shown  in 
Table I, we tried to find whether immunosuppressive factors might be released 
from the mixture of SRBC  and MOLT-4 cells. 4 ml of MOLT-4 cells (1  X  107 
cells/ml) were mixed with  1 ml of 20 %  SRBC  and incubated for 2 h  at 37°C. 
After the  incubation,  the  mixture  was  centrifuged  for  10  min  at  1,800  rpm, 
and the supernate was removed and serially diluted. 0.5 ml of variously diluted 
supernate was added to 0.5  ml of CBA spleen cell suspension containing 4  X 
107 cells/ml and 0.1  ml of 0.1%  SRBC. As controls, SRBC  (20%)  or MOLT-4 
cells alone were incubated and the supernate was removed. The supernate was 
also serially diluted and added to 0.5 ml of CBA spleen cells suspension (4  X 
107  cells/ml) in the presence of 0.1  ml of 0.1%  SRBC. 
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TABLE  II 
Effects of the Supernate  of the Mixture of MOLT-4 Cells and SRBC on  Anti-SRBC  Plaque 
Formation of CBA Spleen Cells 
Mixture of cells  Dilution*  No. of direct plaques~: 
MOLT-4  +  SRBC§  32X  28.9  4-  2.5 
MOLT-4 +  SRBC  64X  33.0  4-  3.2 
MOLT-4 +  SRBC  128X  39.8  4- 20.9 
MOLT-4 +  SRBC  256X  227.3  4- 22.2 
MOLT4IJ  32X  600.6  4-  46.7 
MOLT4  64X  579.3  4-  202.8 
MOLT-4  128X  608.0  4-  77.9 
MOLT-4  256X  531.0  4-  95.1 
SRBC¶  32X  530.7  4-  76.5 
* Dilution of the supernate.  0.5 ml of each diluted supernate was added to 0.5 ml of CBA 
spleen cells (4 X  107/ml) and 0.1 ml of 0.1% SRBC for culture. 
~t Mean 4- standard errors for 12 cultures. 
§ 4 ml of MOLT-4 cell suspension  (1 X  107/ml) was mixed with 1 ml of SRBC  solution 
(20% vol/vol). 
JJ 4 ml of MOLT-4 cell suspension  (1 X  107/ml) was mixed with 1 ml of media. 
¶ 4 ml of media was mixed with 1 ml of SRBC solution (20% vol/vol). 
strong immunosuppressive activity up to 258 times dilution, whereas the super- 
nate  of MOLT-4  (M)  had  no  suppressive activity at  32  times dilution. The 
supernate of the culture of SRBC alone had no influence on the response. 
Effects  of the Ratio of MOLT-4 Cells and SRBC in the Mixture on the Release 
of Immunosuppressive  Factor(s).--Since  SRBC  form rosettes on MOLT-4 cells 
and  the number  of SRBC  formed as rosettes on  MOLT-4  cells depends upon 
the ratio, we wanted to know whether change in the ratio of SRBC and MOLT-4 
cells resulted  in  the  release of factors of different  suppressive potentials. We 
changed  the ratio of SRBC  and MOLT-4 cells from  2.5  to 5,000/1,  and  incu- 
bated  for  2  h.  0.5  ml  of  the  supernate  of each  mixture  was  added  to  spleen 
cells in the presence of 0.1  ml of 0.1% SRBC  as described above. As shown in 
Table  III,  no  influence  was  observed  by  changing  the  ratio  of  SRBC  and 
MOLT-4 cells. 
Effects  of  MOLT-4  Cells  on  Anti-CRBC  Plaque  Formation  of  CBA  Mouse 
Spleen Cells.--MOLT-4  cells do not form rosettes with CRBC,  thus the use of 
CRBC  may decide whether MOLT-4 cells would produce immunosuppressive 
factors  by  interacting  antigens  other  than  SRBC  or  whether  MOLT-4  cells 
forming rosettes might be releasing the factors. Table IV shows the results of 
experiments  in  which  0.5  ml  containing  0.5  or  5  X  105  MOLT-4  cells was 
mixed with 0.5  ml  of 2  X  107  CBA  spleen cells in  the presence of 0.1  ml  of 
0.1%  CRBC.  Plaque tests were performed in the presence of CRBC. MOLT-4 
cells did not suppress or enhance anti-CRBC response of mouse spleen cells at 
the concentration where strong suppressions on anti-SRBC  response were ob- 
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TABLE  III 
FJevts of the Ratio of Numbers of MOLT-4 Cells and  SRBC in the Mixture 
Plaque Formation of Mouse Spleen Cdls In Vitro 
on Hemolytic 
SRBC*  No. of plaques$ 
% 
20  4.5  4-  1.5 
1  1.5  4-  0.5 
0.2  3.5  4-  1.3 
0.1  1.0  -4-  0.7 
0.01  0.3  4-  0.3 
without SRBC§  528.2  4-  72.8 
*  1  ml of MOLT-4 cells (1  X  105/ml) was mixed with 0.1 ml of SRBC of various con- 
centrations for 2 h, and the mixture was centrifuged. The supernate (1 ml) was mixed with 1 
ml of mouse spleen cell suspension (4 X  107/ml), and  1 ml of the mixture was cultured in 
the presence of 0.1 ml of 0.1% SRBC. 
Mean 4- standard errors for 12 cultures. 
§ 1 ml of MOLT-4 cells was mixed with 0.1 ml of culture media, and incubated for 2 h at 
37°C. 
TABLE  IV 
Effects of MOLT-4 Cells on Anti-CRBC Plaque Formation of CBA Mouse Spleen Cells 
No. of spleen cells  No. of MOLT-4 cells added  No. of direct plaques* 
2  X  l0  T  none  1005.9  +  119.4 
I  ×  10  ~  none  347.6  -4-  34.3 
1 ×  107  5 X  105 MOLT-4 cells  307.8  +  97.2 
1 X  107  5 X  104 MOLT-4 cells  305.2  4-  63.0 
* Mean 4- standard errors for 12 cultures. 
Effects of the Supernate of the Mixture of MOLT-4 Cells and CRBC on Anti- 
SRBC and  -CRBC Plaque Formations  of CBA  Mouse Spleen  Cells.--Table  V 
indicates  the  results  of  experiments  in  which  0.5  ml  of  the  supernate  of  the 
mixture of MOLT-4  cells and CRBC  was added  to 0.5 ml of 4  X  l0  T (or 2  X 
107  in  the  case  of  CRBC)  CBA  spleen  cells/ml  in  the  presence  of  0.1  ml  of 
0.1%  SRBC  or  CRBC  and  the mixtures  were  cultured  for plaque  tests.  It  is 
shown that MOLT-4  cells did not release immunosuppressive factors upon con- 
tact  with  CRBC,  because  the  addition  of  the  supernates  to  the  cultures  of 
spleen  cells  did  not  result  in  suppression  of  anti-SRBC  nor  -CRBC  plaque 
formation. 
Effects of the Supernate of the Mixture of MOLT-4 Cells and SRBC on Anti- 
CRBC Plaque Formation of CBA  Mouse Spleen Cells.--Table  VI indicates the 
results of experiments in which the supernate of the mixture of MOLT-4  cells 
and SRBC  was  added  to  CBA  spleen cells and CRBC  to know  the specificity 
of  the immunosuppressive  factors.  It is shown here  that  factors  released  from AKIKAZU TAKADA, YUMIKO TAKADA, AND  JUN  MINOWADA  543 
TABLE V 
Effects of the Supernate of the Mixture of MOLT-4 Cells and CRBC on Anti-SRBC and -CRBC 
Plaque Formation of CBA Mouse Spleen Cells 
Mixture of cells*  Dilution  Antigen  No. of direct plaquesl: 
MOLT-4 cells +  CRBC§  16X  SRBC  408.2  4-  105.6 
MOLT-4 cells +  CRBC  64X  SRBC  432.8  4-  159.7 
MOLT-4 cells +  CRBC  256X  SRBC  427.5  4-  90.2 
MOLT-4 cells[[  16X  SRBC  415.0  4-  28.8 
MOLT4cells  256X  SRBC  440.5  4-  55.9 
MOLT-4 cells +  CRBC  16X  CRBC  295.2  4-  74.4 
MOLT-4 cells +  CRBC  64X  CRBC  384.0  4-  52.8 
MOLT-4 cells +  CRBC  256X  CRBC  360.0  4-  4.8 
MOLT-4 cells  16X  CRBC  347.8  4-  20.8 
MOLT4 cells  256X  CRBC  337.0  4-  112.2 
* 0.1 ml of 0.1% SRBC or CRBC was added to the culture as antigens. 
:~ Mean 4- standard errors for 12 cultures. 
§ 4 ml of MOLT-4 cells (1  X  107/ml) was mixed with 1 ml of 20% CRBC solution for 
incubation. 
[] 4 ml of MOLT-4 cells (1 X  107/ml) was mixed with 1 ml of media. 
TABLE VI 
Effetts  of the Suptrnate  of the Mixture  of MOLT-4 Cells and SRBC  on Anti-CRBC  Plaque 
Formation of CBA Mouse Spleen Cells 
Mixture of cells  Dilution  No. of direct plaques* 
MOLT-4 cells +  SRBC~t  16X  39.8  4- 9.6 
MOLT-4 cells +  SRBC  64X  41.0  ±  7.2 
MOLT-4 cells +  SRBC  256X  49.3  4-  9.3 
MOLT-4 cells§  16X  347.8  4-  20.8 
MOLT-4 cells  256X  337.0  4-  112.2 
* Mean 4- standard errors for 12 cultures. 
:~, § The same procedures described in Table II. 
the mixture of SRBC and MOLT-4 cells suppressed anti-CRBC plaque forma- 
tion of mouse spleen cells, therefore the suppression of the anti-RBC response 
of mouse spleen cells by the factors is not specific to SRBC. 
Effects  of Dialysates  of the  Supernate  of the Mixture  of MOLT-4  Cells  and 
SRBC  on  Anti-SRBC  Plaque  Formation.--The  supernate  of  the  mixture  of 
MOLT-4 cells plus SRBC (M +  S) was obtained as described before and then 
1 ml of the supernate was put inside the central chamber of Marbrook's culture 
unit. 24 h  after keeping the culture unit at  room temperature,  the  dialysate 
(solution outside the central chamber which was attached with dialysis mem- 
brane at the lower end) was removed. 0.5 ml of the dialysate was added to 0.5 
ml of CBA  spleen cell suspension (4  X  107/ml)  in the presence of 0.1  ml of 
0.1% SRBC and cultured. As shown in Table VII, the dialysate of (M  +  S) 544  FUNCTIONS OF  HUMAN T-LYMPHOID CELL LINE  (MOLT) 
TABLE VII 
Effects of Dialysates of the Supernate  of the Mixture of MOLT-4 Cells and SRBC on A nti-SRBC 
Plaque  Formation 
Solution added to the culture  Dilution  No. oI direct  plaques¶ 
dialysate of (M +  S)*  1X  141.5  -4-  30.9 
dialysate of (M):~  1X  538.9  -4-  66.2 
(M +  S) in the inside chamber§  16X  31.5  ±  17.3 
(M) in the inside chamber[[  16X  597.8  ±  83.4 
* The solution of the outside chamber was used for culture.  (M  -t- S) :  the supernate  of 
the mixture of MOLT-4 cells and SRBC.  (M -t- S) was put in the inside chamber. 
~: (M) : the supernate of MOLT-4 cell suspension.  (M) was put in the inside chamber. 
§ (M -t- S) in the inside chamber after 24 h. 
I[ (M) in the inside chamber after 24 h. 
¶ Mean ±  standard errors for 12 cultures. 
showed some immunosuppressive activity although the activity was lower than 
(M  -t- S) inside the chamber. The dialysate of the supernate of MOLT-4 cells 
alone did not have any suppressive effects. 
DISCUSSION 
Lymphocytes are classified into two categories, B  and T  cells. Since Iwakata 
and  Grace (2) succeeded in the permanent culture of a  hematopoietic cell line 
from  the peripheral blood of a  patient with acute myelogenous leukemia, nu- 
merous cell lines have successfully been established. These lymphoid cell lines 
have  B-cell  characteristics,  namely  producing  immunoglobulins  and  having 
receptors for complement  and  antigen-antibody complex. 
Recently Minowada  et  al.  (10,  11)  succeeded  in  the  establishment  of  two 
lymphoid cell lines  (called MOLT  and  SOMMER)  from  the peripheral blood 
of a  patient  of acute  lymphoblastic leukemia.  MOLT  cells did not  have  im- 
munoglobulin on  the surface, nor receptors for antigen-antibody complex, but 
bound  SRBC  to  form  rosettes.  Electron  microscopically, MOLT-4  cells had 
smooth surface characteristic of T  cells (31). The original culture of SOMMER 
cells gave rise to two populations. One, called SOMMER  B  cells, showed B-cell 
characteristics and  had  46  chromosomes  without  markers3 The  other,  called 
SOMMER  T  cells,  had  T-cell  characteristics,  formed  SRBC  rosettes,  and 
karyologically had two typical markers3 
Although the formation of spontaneous rosettes with SRBC  is considered to 
be a  marker for T  cells (6,  12, 32), nothing is known about the functional ac- 
tivities of those rosettes. As shown  in Tables I  and  II, the mixture of SRBC 
and MOLT-4 cells resulted in the release of strong immunosuppressive factors 
2 Huang, C. C., Y. Hou, L. K. Woods, G. E. Moore, and J. Minowada. 1974. Cytogenetic 
study of human lymphoid cell lines with characterization of thymus-derived lymphocytes. 
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in  the  supernate.  Since the  mixture of CRBC  and  MOLT-4 cells, which  do 
not form rosettes with CRBC, did not result in the release of any such factors- 
it is strongly suspected that the origin of the factors may be MOLT cells form, 
ing rosettes. As Table VII shows, some of the factors are dialysable. Recently 
Rubin et al. (33) showed a soluble mediator from allogenic mixtures of human 
B  lymphocytes (RPMI  1788  and 4098)  which  enhanced nonspecifically anti- 
SRBC  response of mouse spleen cells.  So far no factor has been shown to be 
released from human T  cells. 
As  to immunosuppression caused by T  cells,  Tai-You Ha et al.  (34)  have 
shown that thymocytes from rats given a large dose of bovine gamma globulin 
when  transferred  to  syngeneic  recipients,  specifically inhibited  responses  to 
BGG in the recipients. Dutton  (35)  has shown that  the addition of concana- 
valin A to mouse spleen cell cultures gave rise to both stimulating and inhibi- 
tory effects. Dutton postulated that these effects were mediated by two separate 
subpopulations of T cells (36). Because of these experimental results and others, 
much attention has been given to  a  subpopulation  of T  cells,  so called sup- 
pressor T  cells.  However, there is no decisive evidence to indicate that T  cells 
really  produce  immunosuppressive  factors.  The  present  data  indicate  that 
MOLT-4 cells, established human T-lymphoid cells release immunosuppressive 
factors upon  contact with  SRBC.  The present  data do not  imply, however, 
that  all  T-lymphoid cells  forming SRBC  rosettes are  releasing  immunosup- 
pressive factors, nor that T  cells from acute lymphoblastic leukemia are "sup- 
pressor T-cells", but it may be very tempting to speculate that some T-lymph- 
oid  cells  of  leukemia  may  release  immunosuppressive  factors  so  that  these 
leukemic cells may escape from immune  surveillance or attacks  by the  host 
immune system. In fact, Han and Minowada have shown (37)  that MOLT-4 
cells did not stimulate allogeneic human lymphoid cells in the mixed lymphoid 
culture. The lack of stimulation may be mediated by the suppressive factors 
released from MOLT-cells rather than the lack of membrane-associated anti- 
gens (MLR-S; mixed lymphocyte-stimulating determinants [38]). We are cur- 
rently  working  on  isolation  and  characterization  of  these  factors  and  their 
effects on cellular immunity and tumor cells in vitro and in vivo. 
SUMMARY 
A  short  term incubation of the mixture of established human  T-lymphoid 
cells  (MOLT)  and  sheep red  blood  cells  (SRBC)resulted  in  the  release  of 
factors  which  nonspecifically suppressed  the  response  of  mouse  spleen  cells 
against heterologous erythrocytes in vitro. Neither human B-cell line (RPMI 
1788), nor the supernate of MOLT cell suspension in the absence of SRBC had 
such suppressive effects. 
The supernate of the mixture of MOLT cells with  chicken  red blood cells 
(CRBC) did not suppress either anti-CRBC or anti-SRBC responses of mouse 
spleen cells.  Since  CRBC  did not  form rosettes with  MOLT cells,  it  is sus- 546  FUNCTIONS  OF  HUMAN  T-LYMPHOID  CELL  LINE  (MOLT) 
pected that the origin of the production of these factors might be MOLT cells 
forming SRBC rosettes.  Some of these factors are dialysable. 
The  excellent technical  assistance  of Harry Babbitt  and  Raymond Church  is  greatly 
appreciated. 
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